VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $650 | +33.7% | 150,399 | +103.7% | 0.01% | +50.0% |
Q2 2023 | $486 | -99.5% | 73,822 | +631.0% | 0.00% | +300.0% |
Q3 2022 | $100,000 | -93.4% | 10,099 | -92.7% | 0.00% | -94.4% |
Q2 2022 | $1,506,000 | +82.1% | 138,176 | +88.9% | 0.02% | +80.0% |
Q1 2022 | $827,000 | +17.6% | 73,131 | +63.2% | 0.01% | +42.9% |
Q4 2021 | $703,000 | +92.1% | 44,815 | +163.1% | 0.01% | +75.0% |
Q2 2021 | $366,000 | -55.2% | 17,034 | -68.7% | 0.00% | -66.7% |
Q1 2021 | $817,000 | +383.4% | 54,402 | +322.1% | 0.01% | +500.0% |
Q4 2020 | $169,000 | -61.9% | 12,887 | -52.2% | 0.00% | -75.0% |
Q4 2019 | $443,000 | – | 26,968 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |